Life Sciences
Case Study

From risk averse
to addressing risk proactively

Redefining risk for an international healthcare manufacturer

A Skarbek effect case study

One of the leading global healthcare companies in the world asked Skarbek to evolve their current risk management culture and ways of working, address their current challenges and reframe how they view and navigate risk going forward in order to better enable growth from innovation.

Skarbek Associates case study
The needs

The client wanted to evolve its ways of working concerning risk management. Whilst their ability to identify risks was evident, the rigour around risk mitigation was not established and with no common method to frame the risk, or proactive way of tackling risks, this often led to abandoned projects, under-resourced mitigation plans, or delays due to slow decision making. This, coupled with a very risk-averse culture resulted in innovation falling behind, or coming in late compared to the competition. The need was to set them up on a journey to look at risk through a positive lens and equip them to get better at predicting risk and focussing their efforts on increasing the probability of success.

How we helped

Skarbek designed, developed and delivered a bespoke 3 half-day intense risk management programme with the client to first establish the current organisational context for risk, but also to further participants’ knowledge and ability to effectively analyse risk, identify and focus on points of vulnerability and take action to increase their probability of success. Through the introduction of new tools and techniques, such as the ‘pre-mortem’ approach, ‘McRaven graphs’*, and the ‘delivery confidence assessment’, the team were able to develop new tactics to accurately assess and report on risks and therefore prioritise and resource appropriately.

*A Skarbek developed technique inspired by William McRaven’s analysis of success factors in Special Operations Missions.

The results

The Skarbek-led programme provided the client with:

  • A fully aligned cross-functional team with a re-focussed and forward-looking risk management framework, using common language, messaging and methodology to better manage risk.
  • A new perspective and ability to drive quality risk analysis and identify actions that address risks pro-actively.
  • Ongoing action plan and upskilled team with new tools and techniques that can be implemented immediately, enabling streamlined communication across functions and the ability to improve innovation delivery.
  • A transformed mindset within the team towards a more positive culture around risk, an elevated ability to look at risks as opportunities and raise their project probability of success.
  • This programme was evaluated very highly (4.5 / 5) by the 60+ participants and the tools and techniques used were voted to be simple, easily implementable and, once implemented, of very high value to the risk ways of working.

Begin the conversation today!

Tell us who you are and how to contact you, so we can begin to help you

Please confirm you're human.
Business now operates in a persistent crisis. To thrive though needs a continuous evolution of the capabilities needed to implement your strategies; seizing innovation opportunities, securing benefits from change projects; delivering benefits from entering new markets.
Paul Heugh
Skarbek Associates

Andy Grieves

Highly respected global Pharma / Biopharma Operations Executive with over 30 years’ experience

Aline Fornear

Experienced R&D and technical project management professional with extensive experience delivering innovation in the FMCG industry

Marie Salmon

Experienced International project leader with multi sector experience

Rebecca Stephens MBE

First woman to climb the seven summits, inspirational speaker.

General Sir Michael Rose KCB, CBE, DSO, QGM

General Rose is one of Britain's most distingushed soldiers and a former head of UK Special Forces